메뉴 건너뛰기
Clinical and Vaccine Immunology
Volumn 23, Issue 3, 2016, Pages 189-195
Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease
Author keywords

[No Author keywords available]
Indexed keywords

NEUTRALIZING ANTIBODY; RESPIRATORY SYNCYTIAL VIRUS VACCINE; VIRUS ANTIBODY;
EID: 84962596195     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00609-15     Document Type: Review
Times cited : (179)
References (123)
  • 1
    • 77951636537 scopus 로고    scopus 로고
    • Respiratory syncytial virus in young children
    • Hall CB. 2010. Respiratory syncytial virus in young children. Lancet 375:1500-1502. http://dx.doi.org/10.1016/S0140-6736(10)60401-1.
    • (2010) Lancet , vol.375 , pp. 1500-1502
    • Hall, C.B.1
  • 3
    • 0027183229 scopus 로고
    • Acute respiratory illness in the community. Frequency of illness and the agents involved
    • Monto AS, Sullivan KM. 1993. Acute respiratory illness in the community. Frequency of illness and the agents involved. Epidemiol Infect 110: 145-160.
    • (1993) Epidemiol Infect , vol.110 , pp. 145-160
    • Monto, A.S.1    Sullivan, K.M.2
  • 4
    • 0022885642 scopus 로고
    • Acute lower respiratory tract infections in nonhospitalized children
    • Denny FW, Clyde WA, Jr. 1986. Acute lower respiratory tract infections in nonhospitalized children. J Pediatr 108:635-646. http://dx.doi.org/10.1016/S0022-3476(86)81034-4.
    • (1986) J Pediatr , vol.108 , pp. 635-646
    • Denny, F.W.1    Clyde, W.A.2
  • 5
    • 0001765704 scopus 로고
    • Bronchiolitis: Epidemiology, treatment, and prevention
    • Gruber WC. 1995. Bronchiolitis: Epidemiology, treatment, and prevention. Semin Pediatr Infect Dis 6:128-134. http://dx.doi.org/10.1016/S1045-1870(05)80039-1.
    • (1995) Semin Pediatr Infect Dis , vol.6 , pp. 128-134
    • Gruber, W.C.1
  • 6
    • 0032696770 scopus 로고    scopus 로고
    • Bronchiolitis-associated hospitalizations among US children 1980-1996
    • Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. 1999. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 282:1440-1446. http://dx.doi.org/10.1001/jama.282.15.1440.
    • (1999) JAMA , vol.282 , pp. 1440-1446
    • Shay, D.K.1    Holman, R.C.2    Newman, R.D.3    Liu, L.L.4    Stout, J.W.5    Anderson, L.J.6
  • 9
    • 0347320936 scopus 로고    scopus 로고
    • Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections
    • Anonymous.
    • Anonymous. 2003. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics 112:1442-1446. http://dx.doi.org/10.1542/peds.112.6.1442.
    • (2003) Pediatrics , vol.112 , pp. 1442-1446
  • 12
    • 84918535631 scopus 로고    scopus 로고
    • Influenza vaccination of pregnant women and protection of their infants
    • Madhi SA, Nunes MC, Cutland CL. 2014. Influenza vaccination of pregnant women and protection of their infants.NEngl J Med 371:2340. http://dx.doi.org/10.1056/NEJMc1412050.
    • (2014) NEngl J Med , vol.371 , pp. 2340
    • Madhi, S.A.1    Nunes, M.C.2    Cutland, C.L.3
  • 13
    • 77951727193 scopus 로고    scopus 로고
    • Influenza immunization in pregnancy-antibody responses in mothers and infants
    • Steinhoff MC, Omer SB, Roy E, Altaye M, Breiman RF, Zaman K. 2010. Influenza immunization in pregnancy-antibody responses in mothers and infants. N Engl J Med 362:1644-1646. http://dx.doi.org/10.1056/NEJMc0912599.
    • (2010) N Engl J Med , vol.362 , pp. 1644-1646
    • Steinhoff, M.C.1    Omer, S.B.2    Roy, E.3    Altaye, M.4    Breiman, R.F.5    Zaman, K.6
  • 15
    • 84897549196 scopus 로고    scopus 로고
    • Development of an adenovirus-based respiratory syncytial virus vaccine: Preclinical evaluation of efficacy, immunogenicity, and enhanced disease in a cotton rat model
    • Kim E, Okada K, Beeler JA, Crim RL, Piedra PA, Gilbert BE, Gambotto A. 2014. Development of an adenovirus-based respiratory syncytial virus vaccine: Preclinical evaluation of efficacy, immunogenicity, and enhanced disease in a cotton rat model. J Virol 88:5100-5108. http://dx.doi.org/10.1128/JVI.03194-13.
    • (2014) J Virol , vol.88 , pp. 5100-5108
    • Kim, E.1    Okada, K.2    Beeler, J.A.3    Crim, R.L.4    Piedra, P.A.5    Gilbert, B.E.6    Gambotto, A.7
  • 16
    • 84891825171 scopus 로고    scopus 로고
    • Genetic vaccine for respiratory syncytial virus provides protection without disease potentiation
    • Johnson TR, Rangel D, Graham BS, Brough DE, Gall JG. 2014. Genetic vaccine for respiratory syncytial virus provides protection without disease potentiation. Mol Ther 22:196-205. http://dx.doi.org/10.1038/mt.2013.142.
    • (2014) Mol Ther , vol.22 , pp. 196-205
    • Johnson, T.R.1    Rangel, D.2    Graham, B.S.3    De, B.4    Gall, J.G.5
  • 17
    • 84925625998 scopus 로고    scopus 로고
    • A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models
    • Lambert SL, Aslam S, Stillman E, MacPhail M, Nelson C, Ro B, Sweetwood R, Lei YM, Woo JC, Tang RS. 2015. A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models. PLoS One 10:e0119509. http://dx.doi.org/10.1371/journal.pone.0119509.
    • (2015) PLoS One , vol.10 , pp. e0119509
    • Lambert, S.L.1    Aslam, S.2    Stillman, E.3    MacPhail, M.4    Nelson, C.5    Ro, B.6    Sweetwood, R.7    Lei, Y.M.8    Woo, J.C.9    Tang, R.S.10
  • 19
    • 84908007666 scopus 로고    scopus 로고
    • Additive protection induced by mixed virus-like particles presenting respiratory syncytial virus fusion or attachment glycoproteins
    • Lee S, Quan FS, Kwon Y, Sakamoto K, Kang SM, Compans RW, Moore ML. 2014. Additive protection induced by mixed virus-like particles presenting respiratory syncytial virus fusion or attachment glycoproteins. Antiviral Res 111:129-135. http://dx.doi.org/10.1016/j.antiviral.2014.09.005.
    • (2014) Antiviral Res , vol.111 , pp. 129-135
    • Lee, S.1    Quan, F.S.2    Kwon, Y.3    Sakamoto, K.4    Kang, S.M.5    Compans, R.W.6    Moore, M.L.7
  • 21
    • 84906328204 scopus 로고    scopus 로고
    • Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors
    • Yan D, Lee S, Thakkar VD, Luo M, Moore ML, Plemper RK. 2014. Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors. Proc Natl Acad Sci U S A 111:E3441-E3449. http://dx.doi.org/10.1073/pnas.1405198111.
    • (2014) Proc Natl Acad Sci U S A , vol.111 , pp. E3441-E3449
    • Yan, D.1    Lee, S.2    Thakkar, V.D.3    Luo, M.4    Moore, M.L.5    Plemper, R.K.6
  • 24
    • 84881518014 scopus 로고    scopus 로고
    • A protective and safe intranasal RSV vaccine based on a recombinant prefu-sion-like form of the F protein bound to bacterium-like particles
    • Rigter A, Widjaja I, Versantvoort H, Coenjaerts FE, Van Roosmalen M, Leenhouts K, Rottier PJ, Haijema BJ, de Haan CA. 2013. A protective and safe intranasal RSV vaccine based on a recombinant prefu-sion-like form of the F protein bound to bacterium-like particles. PLoS One 8:e71072. http://dx.doi.org/10.1371/journal.pone.0071072.
    • (2013) PLoS One , vol.8 , pp. e71072
    • Rigter, A.1    Widjaja, I.2    Versantvoort, H.3    Coenjaerts, F.E.4    Van Roosmalen, M.5    Leenhouts, K.6    Rottier, P.J.7    Haijema, B.J.8    De Haan, C.A.9
  • 26
  • 27
    • 0014495164 scopus 로고
    • Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population
    • Chin J, Magoffin RL, Shearer LA, Schieble JH, Lennette EH. 1969. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am J Epidemiol 89:449-463.
    • (1969) Am J Epidemiol , vol.89 , pp. 449-463
    • Chin, J.1    Magoffin, R.L.2    Shearer, L.A.3    Schieble, J.H.4    Lennette, E.H.5
  • 28
    • 0014493282 scopus 로고
    • An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine
    • Kapikian AZ, Mitchell RH, Chanock RM, Shvedoff RA, Stewart CE. 1969. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol 89:405-421.
    • (1969) Am J Epidemiol , vol.89 , pp. 405-421
    • Kapikian, A.Z.1    Mitchell, R.H.2    Chanock, R.M.3    Shvedoff, R.A.4    Stewart, C.E.5
  • 29
    • 0014493107 scopus 로고
    • Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; An aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine
    • Fulginiti VA, Eller JJ, Sieber OF, Joyner JW, Minamitani M, Meiklejohn G. 1969. Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am J Epidemiol 89:435-448.
    • (1969) Am J Epidemiol , vol.89 , pp. 435-448
    • Fulginiti, V.A.1    Eller, J.J.2    Sieber, O.F.3    Joyner, J.W.4    Minamitani, M.5    Meiklejohn, G.6
  • 30
    • 0027283977 scopus 로고
    • Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus
    • Graham BS, Henderson GS, Tang YW, Lu X, Neuzil KM, Colley DG. 1993. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J Immunol 151:2032-2040.
    • (1993) J Immunol , vol.151 , pp. 2032-2040
    • Graham, B.S.1    Henderson, G.S.2    Tang, Y.W.3    Lu, X.4    Neuzil, K.M.5    Colley, D.G.6
  • 31
    • 0028110057 scopus 로고
    • Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus
    • Tang YW, Graham BS. 1994. Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus. J Clin Invest 94:1953-1958. http://dx.doi.org/10.1172/JCI117546.
    • (1994) J Clin Invest , vol.94 , pp. 1953-1958
    • Tang, Y.W.1    Graham, B.S.2
  • 32
    • 42149183579 scopus 로고    scopus 로고
    • IL-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccineenhanced disease
    • Castilow EM, Meyerholz DK, Varga SM. 2008. IL-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccineenhanced disease. J Immunol 180:2376-2384. http://dx.doi.org/10.4049/jimmunol.180.4.2376.
    • (2008) J Immunol , vol.180 , pp. 2376-2384
    • Castilow, E.M.1    Meyerholz, D.K.2    Varga, S.M.3
  • 34
    • 0026460748 scopus 로고
    • Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSVimmunized BALB/c mice is abrogated by depletion of CD4-T cells
    • Connors M, Kulkarni AB, Firestone CY, Holmes KL, Morse HC, III, Sotnikov AV, Murphy BR. 1992. Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSVimmunized BALB/c mice is abrogated by depletion of CD4-T cells. J Virol 66:7444-7451.
    • (1992) J Virol , vol.66 , pp. 7444-7451
    • Connors, M.1    Kulkarni, A.B.2    Firestone, C.Y.3    Holmes, K.L.4    Morse, H.C.5    Sotnikov, A.V.6    Murphy, B.R.7
  • 35
    • 0028263755 scopus 로고
    • Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSVimmunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10
    • Connors M, Giese NA, Kulkarni AB, Firestone CY, Morse HC, III, Murphy BR. 1994. Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSVimmunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10. J Virol 68:5321-5325.
    • (1994) J Virol , vol.68 , pp. 5321-5325
    • Connors, M.1    Giese, N.A.2    Kulkarni, A.B.3    Firestone, C.Y.4    Morse, H.C.5    Murphy, B.R.6
  • 36
    • 84874225887 scopus 로고    scopus 로고
    • Defective immunoregulation in RSV vaccine-augmented viral lung disease restored by selective chemoattraction of regulatory T cells
    • Loebbermann J, Durant L, Thornton H, Johansson C, Openshaw PJ. 2013. Defective immunoregulation in RSV vaccine-augmented viral lung disease restored by selective chemoattraction of regulatory T cells. Proc Natl Acad Sci U S A 110:2987-2992. http://dx.doi.org/10.1073/pnas.1217580110.
    • (2013) Proc Natl Acad Sci U S A , vol.110 , pp. 2987-2992
    • Loebbermann, J.1    Durant, L.2    Thornton, H.3    Johansson, C.4    Openshaw, P.J.5
  • 37
    • 84926472303 scopus 로고    scopus 로고
    • RSV vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T cell subsets
    • Knudson CJ, Hartwig SM, Meyerholz DK, Varga SM. 2015. RSV vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T cell subsets. PLoS Pathog 11:e1004757. http://dx.doi.org/10.1371/journal.ppat.1004757.
    • (2015) PLoS Pathog , vol.11 , pp. e1004757
    • Knudson, C.J.1    Hartwig, S.M.2    Meyerholz, D.K.3    Varga, S.M.4
  • 38
    • 0029664574 scopus 로고    scopus 로고
    • Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern
    • Waris ME, Tsou C, Erdman DD, Zaki SR, Anderson LJ. 1996. Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern. J Virol 70: 2852-2860.
    • (1996) J Virol , vol.70 , pp. 2852-2860
    • Waris, M.E.1    Tsou, C.2    Erdman, D.D.3    Zaki, S.R.4    Anderson, L.J.5
  • 39
    • 0030795092 scopus 로고    scopus 로고
    • Virus-specific CD8-T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection
    • Srikiatkhachorn A, Braciale TJ. 1997. Virus-specific CD8-T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. J Exp Med 186:421-432. http://dx.doi.org/10.1084/jem.186.3.421.
    • (1997) J Exp Med , vol.186 , pp. 421-432
    • Srikiatkhachorn, A.1    Braciale, T.J.2
  • 40
    • 0031616713 scopus 로고    scopus 로고
    • The effect of IL-12 treatment on vaccineenhanced illness during infection with respiratory syncytial virus
    • Openshaw PJ, Hussell T. 1998. The effect of IL-12 treatment on vaccineenhanced illness during infection with respiratory syncytial virus. Dev Biol Stand 92:179-185.
    • (1998) Dev Biol Stand , vol.92 , pp. 179-185
    • Openshaw, P.J.1    Hussell, T.2
  • 42
    • 0035200723 scopus 로고    scopus 로고
    • Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine
    • Prince GA, Curtis SJ, Yim KC, Porter DD. 2001. Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine. J Gen Virol 82:2881-2888. http://dx.doi.org/10.1099/0022-1317-82-12-2881.
    • (2001) J Gen Virol , vol.82 , pp. 2881-2888
    • Prince, G.A.1    Curtis, S.J.2    Yim, K.C.3    Porter, D.D.4
  • 45
    • 0036828165 scopus 로고    scopus 로고
    • Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection
    • De Swart RL, Kuiken T, Timmerman HH, Van Amerongen G, Van Den Hoogen BG, Vos HW, Neijens HJ, Andeweg AC, Osterhaus AD. 2002. Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection. J Virol 76:11561-11569. http://dx.doi.org/10.1128/JVI.76.22.11561-11569.2002.
    • (2002) J Virol , vol.76 , pp. 11561-11569
    • De Swart, R.L.1    Kuiken, T.2    Timmerman, H.H.3    Van Amerongen, G.4    Van Den Hoogen, B.G.5    Vos, H.W.6    Neijens, H.J.7    Andeweg, A.C.8    Osterhaus, A.D.9
  • 46
    • 0025052448 scopus 로고
    • Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization
    • Murphy BR, Sotnikov AV, Lawrence LA, Banks SM, Prince GA. 1990. Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization. Vaccine 8:497-502. http://dx.doi.org/10.1016/0264-410X(90)90253-I.
    • (1990) Vaccine , vol.8 , pp. 497-502
    • Murphy, B.R.1    Sotnikov, A.V.2    Lawrence, L.A.3    Banks, S.M.4    Prince, G.A.5
  • 47
    • 0037446912 scopus 로고    scopus 로고
    • Antibody-dependent enhancement, a possible mechanism in augmented pulmonary disease of respiratory syncytial virus in the bonnet monkey model
    • Ponnuraj EM, Springer J, Hayward AR, Wilson H, Simoes EA. 2003. Antibody-dependent enhancement, a possible mechanism in augmented pulmonary disease of respiratory syncytial virus in the bonnet monkey model. J Infect Dis 187:1257-1263. http://dx.doi.org/10.1086/374604.
    • (2003) J Infect Dis , vol.187 , pp. 1257-1263
    • Ponnuraj, E.M.1    Springer, J.2    Hayward, A.R.3    Wilson, H.4    Simoes, E.A.5
  • 48
    • 0032400916 scopus 로고    scopus 로고
    • Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection
    • Hussell T, Georgiou A, Sparer TE, Matthews S, Pala P, Openshaw PJ. 1998. Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection. J Immunol 161:6215-6222.
    • (1998) J Immunol , vol.161 , pp. 6215-6222
    • Hussell, T.1    Georgiou, A.2    Sparer, T.E.3    Matthews, S.4    Pala, P.5    Openshaw, P.J.6
  • 49
    • 0032804395 scopus 로고    scopus 로고
    • Induction of Th-1 and Th-2 responses by respiratory syncytial virus attachment glycoprotein is epitope and major histocompatibility complex independent
    • Srikiatkhachorn A, Chang W, Braciale TJ. 1999. Induction of Th-1 and Th-2 responses by respiratory syncytial virus attachment glycoprotein is epitope and major histocompatibility complex independent. J Virol 73: 6590-6597.
    • (1999) J Virol , vol.73 , pp. 6590-6597
    • Srikiatkhachorn, A.1    Chang, W.2    Braciale, T.J.3
  • 50
    • 0032538913 scopus 로고    scopus 로고
    • Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus
    • Tebbey PW, Hagen M, Hancock GE. 1998. Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus. J Exp Med 188:1967-1972. http://dx.doi.org/10.1084/jem.188.10.1967.
    • (1998) J Exp Med , vol.188 , pp. 1967-1972
    • Tebbey, P.W.1    Hagen, M.2    Hancock, G.E.3
  • 51
    • 0034548224 scopus 로고    scopus 로고
    • The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2 CD4-T cell responses
    • Varga SM, Wissinger EL, Braciale TJ. 2000. The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2 CD4-T cell responses. J Immunol 165:6487-6495. http://dx.doi.org/10.4049/jimmunol.165.11.6487.
    • (2000) J Immunol , vol.165 , pp. 6487-6495
    • Varga, S.M.1    Wissinger, E.L.2    Braciale, T.J.3
  • 53
    • 0014578582 scopus 로고
    • Terminal bronchopneumonia. A bacteriological and histological study of 111 necropsies
    • Lond
    • Tanner EI, Gray JD, Rebello PV, Gamble DR. 1969. Terminal bronchopneumonia. A bacteriological and histological study of 111 necropsies. J Hyg (Lond) 67:477-484.
    • (1969) J Hyg , vol.67 , pp. 477-484
    • Tanner, E.I.1    Gray, J.D.2    Rebello, P.V.3    Gamble, D.R.4
  • 54
    • 0035245104 scopus 로고    scopus 로고
    • Molecular typing demonstrating transmission of gramnegative rods in a neonatal intensive care unit in the absence of a recognized epidemic
    • Almuneef MA, Baltimore RS, Farrel PA, Reagan-Cirincione P, Dembry LM. 2001. Molecular typing demonstrating transmission of gramnegative rods in a neonatal intensive care unit in the absence of a recognized epidemic. Clin Infect Dis 32:220-227. http://dx.doi.org/10.1086/318477.
    • (2001) Clin Infect Dis , vol.32 , pp. 220-227
    • Almuneef, M.A.1    Baltimore, R.S.2    Farrel, P.A.3    Reagan-Cirincione, P.4    Dembry, L.M.5
  • 55
    • 0023154032 scopus 로고
    • Gram-negative bacilli as nontransient flora on the hands of hospital personnel
    • Guenthner SH, Hendley JO, Wenzel RP. 1987. Gram-negative bacilli as nontransient flora on the hands of hospital personnel. J Clin Microbiol 25:488-490.
    • (1987) J Clin Microbiol , vol.25 , pp. 488-490
    • Guenthner, S.H.1    Hendley, J.O.2    Wenzel, R.P.3
  • 56
    • 0025145213 scopus 로고
    • Gram-negative colonization of the respiratory tract: Pathogenesis and clinical consequences
    • Niederman MS. 1990. Gram-negative colonization of the respiratory tract: Pathogenesis and clinical consequences. Semin Respir Infect 5:173-184.
    • (1990) Semin Respir Infect , vol.5 , pp. 173-184
    • Niederman, M.S.1
  • 57
    • 0038402666 scopus 로고    scopus 로고
    • Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidate
    • Plotnicky H, Siegrist CA, Aubry JP, Bonnefoy JY, Corvaia N, Nguyen TN, Power UF. 2003. Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidate. Vaccine 21:2651-2660. http://dx.doi.org/10.1016/S0264-410X(03)00055-0.
    • (2003) Vaccine , vol.21 , pp. 2651-2660
    • Plotnicky, H.1    Siegrist, C.A.2    Aubry, J.P.3    Bonnefoy, J.Y.4    Corvaia, N.5    Nguyen, T.N.6    Power, U.F.7
  • 58
    • 67349253124 scopus 로고    scopus 로고
    • TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity
    • Johnson TR, Rao S, Seder RA, Chen M, Graham BS. 2009. TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity. Vaccine 27:3045-3052. http://dx.doi.org/10.1016/j.vaccine.2009.03.026.
    • (2009) Vaccine , vol.27 , pp. 3045-3052
    • Johnson, T.R.1    Rao, S.2    Seder, R.A.3    Chen, M.4    Graham, B.S.5
  • 59
    • 8644291075 scopus 로고    scopus 로고
    • Protective and disease-enhancing immune responses induced by recombinant modified vaccinia Ankara (MVA) expressing respiratory syncytial virus proteins
    • Olszewska W, Suezer Y, Sutter G, Openshaw PJ. 2004. Protective and disease-enhancing immune responses induced by recombinant modified vaccinia Ankara (MVA) expressing respiratory syncytial virus proteins. Vaccine 23:215-221. http://dx.doi.org/10.1016/j.vaccine.2004.05.015.
    • (2004) Vaccine , vol.23 , pp. 215-221
    • Olszewska, W.1    Suezer, Y.2    Sutter, G.3    Openshaw, P.J.4
  • 60
    • 79960862349 scopus 로고    scopus 로고
    • Absence of vaccine-enhanced RSV disease and changes in pulmonary dendritic cells with adenovirus-based RSV vaccine
    • Krause A, Xu Y, Ross S, Wu W, Joh J, Worgall S. 2011. Absence of vaccine-enhanced RSV disease and changes in pulmonary dendritic cells with adenovirus-based RSV vaccine. Virol J 8:375. http://dx.doi.org/10.1186/1743-422X-8-375.
    • (2011) Virol J , vol.8 , pp. 375
    • Krause, A.1    Xu, Y.2    Ross, S.3    Wu, W.4    Joh, J.5    Worgall, S.6
  • 61
    • 34347243513 scopus 로고    scopus 로고
    • Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology
    • Cyr SL, Jones T, Stoica-Popescu I, Brewer A, Chabot S, Lussier M, Burt D, Ward BJ. 2007. Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology. Vaccine 25:5378-5389. http://dx.doi.org/10.1016/j.vaccine.2007.05.004.
    • (2007) Vaccine , vol.25 , pp. 5378-5389
    • Cyr, S.L.1    Jones, T.2    Stoica-Popescu, I.3    Brewer, A.4    Chabot, S.5    Lussier, M.6    Burt, D.7    Ward, B.J.8
  • 62
    • 77956018092 scopus 로고    scopus 로고
    • Prophylactic treatment with a G glycoprotein monoclonal antibody reduces pulmonary inflammation in respiratory syncytial virus (RSV)-challenged naive and formalin-inactivated RSV-immunized BALB/c mice
    • Radu GU, Caidi H, Miao C, Tripp RA, Anderson LJ, Haynes LM. 2010. Prophylactic treatment with a G glycoprotein monoclonal antibody reduces pulmonary inflammation in respiratory syncytial virus (RSV)-challenged naive and formalin-inactivated RSV-immunized BALB/c mice. J Virol 84:9632-9636. http://dx.doi.org/10.1128/JVI.00451-10.
    • (2010) J Virol , vol.84 , pp. 9632-9636
    • Radu, G.U.1    Caidi, H.2    Miao, C.3    Tripp, R.A.4    Anderson, L.J.5    Haynes, L.M.6
  • 63
    • 0033920379 scopus 로고    scopus 로고
    • Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice
    • Tripp RA, Moore D, Winter J, Anderson LJ. 2000. Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice. J Virol 74:1614-1622. http://dx.doi.org/10.1128/JVI.74.4.1614-1622.2000.
    • (2000) J Virol , vol.74 , pp. 1614-1622
    • Tripp, R.A.1    Moore, D.2    Winter, J.3    Anderson, L.J.4
  • 64
    • 0035194294 scopus 로고    scopus 로고
    • Differential histopathology and chemokine gene expression in lung tissues following respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-or BBG2Na-immunized mice
    • Power UF, Huss T, Michaud V, Plotnicky-Gilquin H, Bonnefoy JY, Nguyen TN. 2001. Differential histopathology and chemokine gene expression in lung tissues following respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-or BBG2Na-immunized mice. J Virol 75:12421-12430. http://dx.doi.org/10.1128/JVI.75.24.12421-12430.2001.
    • (2001) J Virol , vol.75 , pp. 12421-12430
    • Power, U.F.1    Huss, T.2    Michaud, V.3    Plotnicky-Gilquin, H.4    Bonnefoy, J.Y.5    Nguyen, T.N.6
  • 65
    • 0034703854 scopus 로고    scopus 로고
    • Both immunisation with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSVchallenged mice
    • Boelen A, Andeweg A, Kwakkel J, Lokhorst W, Bestebroer T, Dormans J, Kimman T. 2000. Both immunisation with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSVchallenged mice. Vaccine 19:982-991. http://dx.doi.org/10.1016/S0264-410X(00)00213-9.
    • (2000) Vaccine , vol.19 , pp. 982-991
    • Boelen, A.1    Andeweg, A.2    Kwakkel, J.3    Lokhorst, W.4    Bestebroer, T.5    Dormans, J.6    Kimman, T.7
  • 66
    • 0030841316 scopus 로고    scopus 로고
    • Priming with live respiratory syncytial virus (RSV) prevents the enhanced pulmonary inflammatory response seen after RSV challenge in BALB/c mice immunized with formalin-inactivated RSV
    • Waris ME, Tsou C, Erdman DD, Day DB, Anderson LJ. 1997. Priming with live respiratory syncytial virus (RSV) prevents the enhanced pulmonary inflammatory response seen after RSV challenge in BALB/c mice immunized with formalin-inactivated RSV. J Virol 71:6935-6939.
    • (1997) J Virol , vol.71 , pp. 6935-6939
    • Waris, M.E.1    Tsou, C.2    Erdman, D.D.3    Day, D.B.4    Anderson, L.J.5
  • 67
    • 84860764098 scopus 로고    scopus 로고
    • Immunogenicity and protective capacity of a virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice
    • Kamphuis T, Meijerhof T, Stegmann T, Lederhofer J, Wilschut J, de Haan A. 2012. Immunogenicity and protective capacity of a virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice. PLoS One 7:e36812. http://dx.doi.org/10.1371/journal.pone.0036812.
    • (2012) PLoS One , vol.7 , pp. e36812
    • Kamphuis, T.1    Meijerhof, T.2    Stegmann, T.3    Lederhofer, J.4    Wilschut, J.5    De Haan, A.6
  • 68
    • 0032101551 scopus 로고    scopus 로고
    • Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia
    • Sparer TE, Matthews S, Hussell T, Rae AJ, Garcia-Barreno B, Melero JA, Openshaw PJ. 1998. Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia. J Exp Med 187:1921-1926. http://dx.doi.org/10.1084/jem.187.11.1921.
    • (1998) J Exp Med , vol.187 , pp. 1921-1926
    • Sparer, T.E.1    Matthews, S.2    Hussell, T.3    Rae, A.J.4    Garcia-Barreno, B.5    Melero, J.A.6    Openshaw, P.J.7
  • 69
    • 0031181334 scopus 로고    scopus 로고
    • IL-12 treatment attenuates T helper cell type 2 and B cell responses but does not improve vaccineenhanced lung illness
    • Hussell T, Khan U, Openshaw P. 1997. IL-12 treatment attenuates T helper cell type 2 and B cell responses but does not improve vaccineenhanced lung illness. J Immunol 159:328-334.
    • (1997) J Immunol , vol.159 , pp. 328-334
    • Hussell, T.1    Khan, U.2    Openshaw, P.3
  • 70
    • 0031820378 scopus 로고    scopus 로고
    • Abundant IFN-gamma production by local T cells in respiratory syncytial virus-induced eosinophilic lung disease
    • Spender LC, Hussell T, Openshaw PJ. 1998. Abundant IFN-gamma production by local T cells in respiratory syncytial virus-induced eosinophilic lung disease. J Gen Virol 79(Pt 7):1751-1758. http://dx.doi.org/10.1099/0022-1317-79-7-1751.
    • (1998) J Gen Virol , vol.79 , pp. 1751-1758
    • Spender, L.C.1    Hussell, T.2    Openshaw, P.J.3
  • 71
    • 64849084953 scopus 로고    scopus 로고
    • Fas ligand is required for the development of respiratory syncytial virus vaccine-enhanced disease
    • Olson MR, Varga SM. 2009. Fas ligand is required for the development of respiratory syncytial virus vaccine-enhanced disease. J Immunol 182: 3024-3031. http://dx.doi.org/10.4049/jimmunol.0803585.
    • (2009) J Immunol , vol.182 , pp. 3024-3031
    • Olson, M.R.1    Varga, S.M.2
  • 72
    • 0027404364 scopus 로고
    • The cytolytic activity of pulmonary CD8-lymphocytes, induced by infection with a vaccinia virus recombinant expressing theM2protein of respiratory syncytial virus (RSV), correlates with resistance to RSV infection in mice
    • Kulkarni AB, Connors M, Firestone CY, Morse HC, III, Murphy BR. 1993. The cytolytic activity of pulmonary CD8-lymphocytes, induced by infection with a vaccinia virus recombinant expressing theM2protein of respiratory syncytial virus (RSV), correlates with resistance to RSV infection in mice. J Virol 67:1044-1049.
    • (1993) J Virol , vol.67 , pp. 1044-1049
    • Kulkarni, A.B.1    Connors, M.2    Firestone, C.Y.3    Morse, H.C.4    Murphy, B.R.5
  • 73
    • 0026564788 scopus 로고
    • Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8-T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodies
    • Connors M, Kulkarni AB, Collins PL, Firestone CY, Holmes KL, Morse HC, III, Murphy BR. 1992. Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8-T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodies. J Virol 66:1277-1281.
    • (1992) J Virol , vol.66 , pp. 1277-1281
    • Connors, M.1    Kulkarni, A.B.2    Collins, P.L.3    Firestone, C.Y.4    Holmes, K.L.5    Morse, H.C.6    Murphy, B.R.7
  • 74
    • 0025973901 scopus 로고
    • Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived
    • Connors M, Collins PL, Firestone CY, Murphy BR. 1991. Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived. J Virol 65:1634-1637.
    • (1991) J Virol , vol.65 , pp. 1634-1637
    • Connors, M.1    Collins, P.L.2    Firestone, C.Y.3    Murphy, B.R.4
  • 76
    • 38449084342 scopus 로고    scopus 로고
    • CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease
    • Olson MR, Varga SM. 2007. CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease. J Immunol 179:5415-5424. http://dx.doi.org/10.4049/jimmunol.179.8.5415.
    • (2007) J Immunol , vol.179 , pp. 5415-5424
    • Olson, M.R.1    Varga, S.M.2
  • 77
    • 71849118589 scopus 로고    scopus 로고
    • The number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia
    • Olson MR, Hartwig SM, Varga SM. 2008. The number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia. J Immunol 181:7958-7968. http://dx.doi.org/10.4049/jimmunol.181.11.7958.
    • (2008) J Immunol , vol.181 , pp. 7958-7968
    • Olson, M.R.1    Hartwig, S.M.2    Varga, S.M.3
  • 78
    • 0034839922 scopus 로고    scopus 로고
    • Construction and characterization of recombinant vaccinia viruses co-expressing a respiratory syncytial virus protein and a cytokine
    • Johnson TR, Fischer JE, Graham BS. 2001. Construction and characterization of recombinant vaccinia viruses co-expressing a respiratory syncytial virus protein and a cytokine. J Gen Virol 82:2107-2116. http://dx.doi.org/10.1099/0022-1317-82-9-2107.
    • (2001) J Gen Virol , vol.82 , pp. 2107-2116
    • Johnson, T.R.1    Fischer, J.E.2    Graham, B.S.3
  • 79
    • 0037442010 scopus 로고    scopus 로고
    • IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge
    • Johnson TR, Parker RA, Johnson JE, Graham BS. 2003. IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge. J Immunol 170:2037-2045. http://dx.doi.org/10.4049/jimmunol.170.4.2037.
    • (2003) J Immunol , vol.170 , pp. 2037-2045
    • Johnson, T.R.1    Parker, R.A.2    Johnson, J.E.3    Graham, B.S.4
  • 80
    • 0034672004 scopus 로고    scopus 로고
    • IL-12-activated NK cells reduce lung eosinophilia to the attachment protein of respiratory syncytial virus but do not enhance the severity of illness in CD8 T cellimmunodeficient conditions
    • Hussell T, Openshaw PJ. 2000. IL-12-activated NK cells reduce lung eosinophilia to the attachment protein of respiratory syncytial virus but do not enhance the severity of illness in CD8 T cellimmunodeficient conditions. J Immunol 165:7109-7115. http://dx.doi.org/10.4049/jimmunol.165.12.7109.
    • (2000) J Immunol , vol.165 , pp. 7109-7115
    • Hussell, T.1    Openshaw, P.J.2
  • 81
    • 0032824135 scopus 로고    scopus 로고
    • Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism
    • Johnson TR, Graham BS. 1999. Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism. J Virol 73:8485-8495.
    • (1999) J Virol , vol.73 , pp. 8485-8495
    • Johnson, T.R.1    Graham, B.S.2
  • 82
    • 3543120025 scopus 로고    scopus 로고
    • Vbeta14(-) T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSV
    • Johnson TR, Varga SM, Braciale TJ, Graham BS. 2004. Vbeta14(-) T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSV. J Virol 78:8753-8760. http://dx.doi.org/10.1128/JVI.78.16.8753-8760.2004.
    • (2004) J Virol , vol.78 , pp. 8753-8760
    • Johnson, T.R.1    Varga, S.M.2    Braciale, T.J.3    Graham, B.S.4
  • 83
    • 0031925039 scopus 로고    scopus 로고
    • Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge
    • Johnson TR, Johnson JE, Roberts SR, Wertz GW, Parker RA, Graham BS. 1998. Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge. J Virol 72:2871-2880.
    • (1998) J Virol , vol.72 , pp. 2871-2880
    • Johnson, T.R.1    Johnson, J.E.2    Roberts, S.R.3    Wertz, G.W.4    Parker, R.A.5    Graham, B.S.6
  • 84
    • 0032728375 scopus 로고    scopus 로고
    • Priming with a secreted form of the fusion protein of respiratory syncytial virus (RSV) promotes interleukin-4 (IL-4) and IL-5 production but not pulmonary eosinophilia following RSV challenge
    • Bembridge GP, Lopez JA, Bustos R, Melero JA, Cook R, Mason H, Taylor G. 1999. Priming with a secreted form of the fusion protein of respiratory syncytial virus (RSV) promotes interleukin-4 (IL-4) and IL-5 production but not pulmonary eosinophilia following RSV challenge. J Virol 73:10086-10094.
    • (1999) J Virol , vol.73 , pp. 10086-10094
    • Bembridge, G.P.1    Lopez, J.A.2    Bustos, R.3    Melero, J.A.4    Cook, R.5    Mason, H.6    Taylor, G.7
  • 85
    • 39749187575 scopus 로고    scopus 로고
    • Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infection
    • Yu JR, Kim S, Lee JB, Chang J. 2008. Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infection. J Virol 82:2350-2357. http://dx.doi.org/10.1128/JVI.02372-07.
    • (2008) J Virol , vol.82 , pp. 2350-2357
    • Yu, J.R.1    Kim, S.2    Lee, J.B.3    Chang, J.4
  • 86
    • 4544329925 scopus 로고    scopus 로고
    • Recombinant respiratory syncytial virus lacking secreted glycoprotein G is attenuated, non-pathogenic but induces protective immunity
    • Maher CF, Hussell T, Blair E, Ring CJ, Openshaw PJ. 2004. Recombinant respiratory syncytial virus lacking secreted glycoprotein G is attenuated, non-pathogenic but induces protective immunity. Microbes Infect 6:1049-1055. http://dx.doi.org/10.1016/j.micinf.2004.07.001.
    • (2004) Microbes Infect , vol.6 , pp. 1049-1055
    • Maher, C.F.1    Hussell, T.2    Blair, E.3    Ring, C.J.4    Openshaw, P.J.5
  • 87
    • 67849134920 scopus 로고    scopus 로고
    • Pulmonary eosinophilia is attenuated by early responding CD8(-) memory T cells in a murine model of RSV vaccine-enhanced disease
    • Stevens WW, Sun J, Castillo JP, Braciale TJ. 2009. Pulmonary eosinophilia is attenuated by early responding CD8(-) memory T cells in a murine model of RSV vaccine-enhanced disease. Viral Immunol 22:243-251. http://dx.doi.org/10.1089/vim.2009.0016.
    • (2009) Viral Immunol , vol.22 , pp. 243-251
    • Stevens, W.W.1    Sun, J.2    Castillo, J.P.3    Braciale, T.J.4
  • 88
    • 0031003252 scopus 로고    scopus 로고
    • Determinants and kinetics of cytokine expression patterns in lungs of vaccinated mice challenged with respiratory syncytial virus
    • Tang YW, Neuzil KM, Fischer JE, Robinson FW, Parker RA, Graham BS. 1997. Determinants and kinetics of cytokine expression patterns in lungs of vaccinated mice challenged with respiratory syncytial virus. Vaccine 15:597-602. http://dx.doi.org/10.1016/S0264-410X(96)00214-9.
    • (1997) Vaccine , vol.15 , pp. 597-602
    • Tang, Y.W.1    Neuzil, K.M.2    Fischer, J.E.3    Robinson, F.W.4    Parker, R.A.5    Graham, B.S.6
  • 89
    • 0033827574 scopus 로고    scopus 로고
    • Respiratory syncytial virus (RSV)-induced airway hyperresponsiveness in allergically sensitized mice is inhibited by live RSV and exacerbated by formalin-inactivated RSV
    • Peebles RS, Jr, Sheller JR, Collins RD, Jarzecka K, Mitchell DB, Graham BS. 2000. Respiratory syncytial virus (RSV)-induced airway hyperresponsiveness in allergically sensitized mice is inhibited by live RSV and exacerbated by formalin-inactivated RSV. J Infect Dis 182:671-677. http://dx.doi.org/10.1086/315783.
    • (2000) J Infect Dis , vol.182 , pp. 671-677
    • Peebles, R.S.1    Sheller, J.R.2    Collins, R.D.3    Jarzecka, K.4    Mitchell, D.B.5    Graham, B.S.6
  • 90
    • 79960319416 scopus 로고    scopus 로고
    • A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced disease
    • Lindell DM, Morris SB, White MP, Kallal LE, Lundy PK, Hamouda T, Baker JR, Jr, Lukacs NW. 2011. A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced disease. PLoS One 6:e21823. http://dx.doi.org/10.1371/journal.pone.0021823.
    • (2011) PLoS One , vol.6 , pp. e21823
    • Lindell, D.M.1    Morris, S.B.2    White, M.P.3    Kallal, L.E.4    Lundy, P.K.5    Hamouda, T.6    Baker, J.R.7    Lukacs, N.W.8
  • 91
    • 0029074792 scopus 로고
    • Pathogenesis of respiratory syncytial virus vaccineaugmented pathology
    • Graham BS. 1995. Pathogenesis of respiratory syncytial virus vaccineaugmented pathology. Am J Respir Crit Care Med 152:S63-S66. http://dx.doi.org/10.1164/ajrccm/152.4-Pt-2.S63.
    • (1995) Am J Respir Crit Care Med , vol.152 , pp. S63-S66
    • Graham, B.S.1
  • 92
    • 0029057010 scopus 로고
    • Immunity and immunopathology to respiratory syncytial virus. the mouse model
    • Openshaw PJ. 1995. Immunity and immunopathology to respiratory syncytial virus. The mouse model. Am J Respir Crit Care Med 152:S59-S62. http://dx.doi.org/10.1164/ajrccm/152.4-Pt-2.S59.
    • (1995) Am J Respir Crit Care Med , vol.152 , pp. S59-S62
    • Openshaw, P.J.1
  • 93
    • 0022555443 scopus 로고
    • Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine
    • Murphy BR, Prince GA, Walsh EE, Kim HW, Parrott RH, Hemming VG, Rodriguez WJ, Chanock RM. 1986. Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine. J Clin Microbiol 24:197-202.
    • (1986) J Clin Microbiol , vol.24 , pp. 197-202
    • Murphy, B.R.1    Prince, G.A.2    Walsh, E.E.3    Kim, H.W.4    Parrott, R.H.5    Hemming, V.G.6    Rodriguez, W.J.7    Chanock, R.M.8
  • 94
    • 0029817240 scopus 로고    scopus 로고
    • Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus
    • Hancock GE, Speelman DJ, Heers K, Bortell E, Smith J, Cosco C. 1996. Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus. J Virol 70:7783-7791.
    • (1996) J Virol , vol.70 , pp. 7783-7791
    • Hancock, G.E.1    Speelman, D.J.2    Heers, K.3    Bortell, E.4    Smith, J.5    Cosco, C.6
  • 95
    • 0026572710 scopus 로고
    • Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G
    • Openshaw PJ, Clarke SL, Record FM. 1992. Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G. Int Immunol 4:493-500. http://dx.doi.org/10.1093/intimm/4.4.493.
    • (1992) Int Immunol , vol.4 , pp. 493-500
    • Openshaw, P.J.1    Clarke, S.L.2    Record, F.M.3
  • 96
    • 33746858063 scopus 로고    scopus 로고
    • A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines
    • Moghaddam A, Olszewska W, Wang B, Tregoning JS, Helson R, Sattentau QJ, Openshaw PJ. 2006. A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines. Nat Med 12: 905-907. http://dx.doi.org/10.1038/nm1456.
    • (2006) Nat Med , vol.12 , pp. 905-907
    • Moghaddam, A.1    Olszewska, W.2    Wang, B.3    Tregoning, J.S.4    Helson, R.5    Sattentau, Q.J.6    Openshaw, P.J.7
  • 97
    • 13844276557 scopus 로고    scopus 로고
    • CpGoligodeoxynucleotides inhibit RSV-enhanced allergic sensitisation in Guinea pigs
    • Tayyari F, Sutton TC, Manson HE, Hegele RG. 2005. CpGoligodeoxynucleotides inhibit RSV-enhanced allergic sensitisation in guinea pigs. Eur Respir J 25:295-302. http://dx.doi.org/10.1183/09031936.05.00016304.
    • (2005) Eur Respir J , vol.25 , pp. 295-302
    • Tayyari, F.1    Sutton, T.C.2    Manson, H.E.3    Hegele, R.G.4
  • 98
    • 2442688932 scopus 로고    scopus 로고
    • Timing of infection and prior immunization with respiratory syncytial virus (RSV) in RSV-enhanced allergic inflammation
    • Barends M, Van Oosten M, De Rond CG, Dormans JA, Osterhaus AD, Neijens HJ, Kimman TG. 2004. Timing of infection and prior immunization with respiratory syncytial virus (RSV) in RSV-enhanced allergic inflammation. J Infect Dis 189:1866-1872. http://dx.doi.org/10.1086/386341.
    • (2004) J Infect Dis , vol.189 , pp. 1866-1872
    • Barends, M.1    Van Oosten, M.2    De Rond, C.G.3    Dormans, J.A.4    Osterhaus, A.D.5    Neijens, H.J.6    Kimman, T.G.7
  • 99
    • 0033837473 scopus 로고    scopus 로고
    • Critical roles for interleukin-4 and interleukin-5 during respiratory syncytial virus infection in the development of airway hyperresponsiveness after airway sensitization
    • Schwarze J, Cieslewicz G, Joetham A, Ikemura T, Makela MJ, Dakhama A, Shultz LD, Lamers MC, Gelfand EW. 2000. Critical roles for interleukin-4 and interleukin-5 during respiratory syncytial virus infection in the development of airway hyperresponsiveness after airway sensitization. Am J Respir Crit Care Med 162:380-386. http://dx.doi.org/10.1164/ajrccm.162.2.9903057.
    • (2000) Am J Respir Crit Care Med , vol.162 , pp. 380-386
    • Schwarze, J.1    Cieslewicz, G.2    Joetham, A.3    Ikemura, T.4    Makela, M.J.5    Dakhama, A.6    Shultz, L.D.7    Lamers, M.C.8    Gelfand, E.W.9
  • 100
    • 77952552645 scopus 로고    scopus 로고
    • Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection
    • Kim S, Jang JE, Yu JR, Chang J. 2010. Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection. Vaccine 28:3801-3808. http://dx.doi.org/10.1016/j.vaccine.2010.03.032.
    • (2010) Vaccine , vol.28 , pp. 3801-3808
    • Kim, S.1    Jang, J.E.2    Yu, J.R.3    Chang, J.4
  • 101
    • 0037234950 scopus 로고    scopus 로고
    • Interferon-gamma levels in nasopharyngeal secretions of infants with respiratory syncytial virus and other respiratory viral infections
    • Joshi P, Shaw A, Kakakios A, Isaacs D. 2003. Interferon-gamma levels in nasopharyngeal secretions of infants with respiratory syncytial virus and other respiratory viral infections. Clin Exp Immunol 131:143-147. http://dx.doi.org/10.1046/j.1365-2249.2003.02039.x.
    • (2003) Clin Exp Immunol , vol.131 , pp. 143-147
    • Joshi, P.1    Shaw, A.2    Kakakios, A.3    Isaacs, D.4
  • 102
    • 77950446204 scopus 로고    scopus 로고
    • Opposing roles of IL-17A and IL-25 in the regulation of TSLP production in human nasal epithelial cells
    • Xu G, Zhang L, Wang DY, Xu R, Liu Z, Han DM, Wang XD, Zuo KJ, Li HB. 2010. Opposing roles of IL-17A and IL-25 in the regulation of TSLP production in human nasal epithelial cells. Allergy 65:581-589. http://dx.doi.org/10.1111/j.1398-9995.2009.02252.x.
    • (2010) Allergy , vol.65 , pp. 581-589
    • Xu, G.1    Zhang, L.2    Wang, D.Y.3    Xu, R.4    Liu, Z.5    Han, D.M.6    Wang, X.D.7    Zuo, K.J.8    Li, H.B.9
  • 103
    • 66949123901 scopus 로고    scopus 로고
    • A functional IL-13 receptor is expressed on polarized murine CD4-Th17 cells and IL-13 signaling attenuates Th17 cytokine production
    • Newcomb DC, Zhou W, Moore ML, Goleniewska K, Hershey GK, Kolls JK, Peebles RS, Jr. 2009. A functional IL-13 receptor is expressed on polarized murine CD4-Th17 cells and IL-13 signaling attenuates Th17 cytokine production. J Immunol 182:5317-5321. http://dx.doi.org/10.4049/jimmunol.0803868.
    • (2009) J Immunol , vol.182 , pp. 5317-5321
    • Newcomb, D.C.1    Zhou, W.2    Moore, M.L.3    Goleniewska, K.4    Hershey, G.K.5    Kolls, J.K.6    Peebles, R.S.7
  • 104
    • 85027091618 scopus 로고    scopus 로고
    • S25 IL 17 production in primary and secondary respiratory syncytial virus (RSV) infection and neutrophil transmigration
    • Ugonna KB, Plant K, Everard ML. 2010. S25 IL 17 production in primary and secondary respiratory syncytial virus (RSV) infection and neutrophil transmigration. Thorax 65(Suppl 4):A14. http://dx.doi.org/10.1136/thx.2010.150912.25.
    • (2010) Thorax , vol.65 , pp. A14
    • Ugonna, K.B.1    Plant, K.2    Everard, M.L.3
  • 106
    • 0141684561 scopus 로고    scopus 로고
    • A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles
    • Polack FP, Hoffman SJ, Crujeiras G, Griffin DE. 2003. A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles. Nat Med 9:1209-1213. http://dx.doi.org/10.1038/nm918.
    • (2003) Nat Med , vol.9 , pp. 1209-1213
    • Polack, F.P.1    Hoffman, S.J.2    Crujeiras, G.3    Griffin, D.E.4
  • 107
    • 0033031217 scopus 로고    scopus 로고
    • Production of atypical measles in rhesus macaques: Evidence for disease mediated by immune complex formation and eosinophils in the presence of fusioninhibiting antibody
    • Polack FP, Auwaerter PG, Lee SH, Nousari HC, Valsamakis A, Leiferman KM, Diwan A, Adams RJ, Griffin DE. 1999. Production of atypical measles in rhesus macaques: Evidence for disease mediated by immune complex formation and eosinophils in the presence of fusioninhibiting antibody. Nat Med 5:629-634. http://dx.doi.org/10.1038/9473.
    • (1999) Nat Med , vol.5 , pp. 629-634
    • Polack, F.P.1    Auwaerter, P.G.2    Lee, S.H.3    Nousari, H.C.4    Valsamakis, A.5    Leiferman, K.M.6    Diwan, A.7    Adams, R.J.8    Griffin, D.E.9
  • 108
    • 0033053331 scopus 로고    scopus 로고
    • Acomplex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site
    • Fleury D, Barrere B, Bizebard T, Daniels RS, Skehel JJ, Knossow M. 1999.Acomplex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site. Nat Struct Biol 6:530-534.http://dx.doi.org/10.1038/9299.
    • (1999) Nat Struct Biol , vol.6 , pp. 530-534
    • Fleury, D.1    Barrere, B.2    Bizebard, T.3    Daniels, R.S.4    Skehel, J.J.5    Knossow, M.6
  • 110
    • 0024466223 scopus 로고
    • Hemagglutinins from two influenza virus variants bind to sialic acid derivatives with millimolar dissociation constants: A 500-MHz proton nuclear magnetic resonance study
    • Sauter NK, Bednarski MD, Wurzburg BA, Hanson JE, Whitesides GM, Skehel JJ, Wiley DC. 1989. Hemagglutinins from two influenza virus variants bind to sialic acid derivatives with millimolar dissociation constants: A 500-MHz proton nuclear magnetic resonance study. Biochemistry 28:8388-8396. http://dx.doi.org/10.1021/bi00447a018.
    • (1989) Biochemistry , vol.28 , pp. 8388-8396
    • Sauter, N.K.1    Bednarski, M.D.2    Wurzburg, B.A.3    Hanson, J.E.4    Whitesides, G.M.5    Skehel, J.J.6    Wiley, D.C.7
  • 111
    • 0015146004 scopus 로고
    • Biologic significance of the secretory A immunoglobulins
    • Bellanti JA. 1971. Biologic significance of the secretory A immunoglobulins. Pediatrics 48:715-729.
    • (1971) Pediatrics , vol.48 , pp. 715-729
    • Bellanti, J.A.1
  • 113
    • 0031683919 scopus 로고    scopus 로고
    • Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants
    • Anonymous. The IMpact-RSV Study Group
    • Anonymous. 1998. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics 102:531-537.
    • (1998) Pediatrics , vol.102 , pp. 531-537
  • 114
    • 34748850172 scopus 로고    scopus 로고
    • The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines
    • Wright PF, Karron RA, Belshe RB, Shi JR, Randolph VB, Collins PL, O'Shea AF, Gruber WC, Murphy BR. 2007. The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines. Vaccine 25:7372-7378. http://dx.doi.org/10.1016/j.vaccine.2007.08.014.
    • (2007) Vaccine , vol.25 , pp. 7372-7378
    • Wright, P.F.1    Karron, R.A.2    Belshe, R.B.3    Shi, J.R.4    Randolph, V.B.5    Collins, P.L.6    O'Shea, A.F.7    Gruber, W.C.8    Murphy, B.R.9
  • 115
    • 0028086033 scopus 로고
    • Respiratory syncytial virus infections in human beings and in cattle
    • Van Der Poel WH, Brand A, Kramps JA, Van Oirschot JT. 1994. Respiratory syncytial virus infections in human beings and in cattle. J Infect 29:215-228. http://dx.doi.org/10.1016/S0163-4453(94)90866-4.
    • (1994) J Infect , vol.29 , pp. 215-228
    • Van Der Poel, W.H.1    Brand, A.2    Kramps, J.A.3    Van Oirschot, J.T.4
  • 116
    • 34147098906 scopus 로고    scopus 로고
    • Bovine respiratory syncytial virus infection
    • Valarcher JF, Taylor G. 2007. Bovine respiratory syncytial virus infection. Vet Res 38:153-180. http://dx.doi.org/10.1051/vetres:2006053.
    • (2007) Vet Res , vol.38 , pp. 153-180
    • Valarcher, J.F.1    Taylor, G.2
  • 117
    • 0036898212 scopus 로고    scopus 로고
    • Replication and clearance of respiratory syncytial virus: Apoptosis is an important pathway of virus clearance after experimental infection with bovine respiratory syncytial virus
    • Viuff B, Tjornehoj K, Larsen LE, Rontved CM, Uttenthal A, Ronsholt L, Alexandersen S. 2002. Replication and clearance of respiratory syncytial virus: Apoptosis is an important pathway of virus clearance after experimental infection with bovine respiratory syncytial virus. Am J Pathol 161:2195-2207. http://dx.doi.org/10.1016/S0002-9440(10)64496-3.
    • (2002) Am J Pathol , vol.161 , pp. 2195-2207
    • Viuff, B.1    Tjornehoj, K.2    Larsen, L.E.3    Rontved, C.M.4    Uttenthal, A.5    Ronsholt, L.6    Alexandersen, S.7
  • 118
    • 15544389510 scopus 로고    scopus 로고
    • Efficacy of a saponinadjuvanted inactivated respiratory syncytial virus vaccine in calves
    • Ellis JA, West KH, Waldner C, Rhodes C. 2005. Efficacy of a saponinadjuvanted inactivated respiratory syncytial virus vaccine in calves. Can Vet J 46:155-162.
    • (2005) Can Vet J , vol.46 , pp. 155-162
    • Ellis, J.A.1    West, K.H.2    Waldner, C.3    Rhodes, C.4
  • 119
    • 0021740449 scopus 로고
    • A comparison of three vaccines against respiratory syncytial virus in calves
    • Lond
    • Stott EJ, Thomas LH, Taylor G, Collins AP, Jebbett J, Crouch S. 1984. A comparison of three vaccines against respiratory syncytial virus in calves. J Hyg (Lond) 93:251-261. http://dx.doi.org/10.1017/S0022172400064779.
    • (1984) J Hyg , vol.93 , pp. 251-261
    • Stott, E.J.1    Thomas, L.H.2    Taylor, G.3    Collins, A.P.4    Jebbett, J.5    Crouch, S.6
  • 120
    • 0035223763 scopus 로고    scopus 로고
    • Bovine respiratory syncytial virus (BRSV) pneumonia in beef calf herds despite vaccination
    • Larsen LE, Tegtmeier C, Pedersen E. 2001. Bovine respiratory syncytial virus (BRSV) pneumonia in beef calf herds despite vaccination. Acta Vet Scand 42:113-121. http://dx.doi.org/10.1186/1751-0147-42-113.
    • (2001) Acta Vet Scand , vol.42 , pp. 113-121
    • Larsen, L.E.1    Tegtmeier, C.2    Pedersen, E.3
  • 121
    • 0033796166 scopus 로고    scopus 로고
    • High mortality rate associated with bovine respiratory syncytial virus (BRSV) infection in Belgian white blue calves previously vaccinated with an inactivated BRSV vaccine
    • Schreiber P, Matheise JP, Dessy F, Heimann M, Letesson JJ, Coppe P, Collard A. 2000. High mortality rate associated with bovine respiratory syncytial virus (BRSV) infection in Belgian white blue calves previously vaccinated with an inactivated BRSV vaccine. J Vet Med B Infect Dis Vet Public Health 47:535-550. http://dx.doi.org/10.1046/j.1439-0450.2000.00380.x.
    • (2000) J Vet Med B Infect Dis Vet Public Health , vol.47 , pp. 535-550
    • Schreiber, P.1    Matheise, J.P.2    Dessy, F.3    Heimann, M.4    Letesson, J.J.5    Coppe, P.6    Collard, A.7
  • 122
    • 0242331736 scopus 로고    scopus 로고
    • Vaccine-induced immunopathology during bovine respiratory syncytial virus infection: Exploring the parameters of pathogenesis
    • Antonis AF, Schrijver RS, Daus F, Steverink PJ, Stockhofe N, Hensen EJ, Langedijk JP, Van Der Most RG. 2003. Vaccine-induced immunopathology during bovine respiratory syncytial virus infection: Exploring the parameters of pathogenesis. J Virol 77:12067-12073. http://dx.doi.org/10.1128/JVI.77.22.12067-12073.2003.
    • (2003) J Virol , vol.77 , pp. 12067-12073
    • Antonis, A.F.1    Schrijver, R.S.2    Daus, F.3    Steverink, P.J.4    Stockhofe, N.5    Hensen, E.J.6    Langedijk, J.P.7    Van Der Most, R.G.8
  • 123
    • 0033605320 scopus 로고    scopus 로고
    • The effect of formalin-inactivated vaccine on respiratory disease associated with bovine respiratory syncytial virus infection in calves
    • West K, Petrie L, Haines DM, Konoby C, Clark EG, Martin K, Ellis JA. 1999. The effect of formalin-inactivated vaccine on respiratory disease associated with bovine respiratory syncytial virus infection in calves. Vaccine 17:809-820. http://dx.doi.org/10.1016/S0264-410X(98)00265-5.
    • (1999) Vaccine , vol.17 , pp. 809-820
    • West, K.1    Petrie, L.2    Haines, D.M.3    Konoby, C.4    Clark, E.G.5    Martin, K.6    Ellis, J.A.7

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.